Zura Bio Statistics
Total Valuation
Zura Bio has a market cap or net worth of $133.29 million. The enterprise value is -$21.20 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, before market open.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Zura Bio has 65.02 million shares outstanding. The number of shares has increased by 69.23% in one year.
Current Share Class | 65.02M |
Shares Outstanding | 65.02M |
Shares Change (YoY) | +69.23% |
Shares Change (QoQ) | +1.43% |
Owned by Insiders (%) | 6.91% |
Owned by Institutions (%) | 40.97% |
Float | 37.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.01 |
P/TBV Ratio | 1.06 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.40
Current Ratio | 8.40 |
Quick Ratio | 8.26 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.55% and return on invested capital (ROIC) is -29.07%.
Return on Equity (ROE) | -43.55% |
Return on Assets (ROA) | -26.05% |
Return on Invested Capital (ROIC) | -29.07% |
Return on Capital Employed (ROCE) | -52.02% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.18M |
Employee Count | 30 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.58% in the last 52 weeks. The beta is -0.06, so Zura Bio's price volatility has been lower than the market average.
Beta (5Y) | -0.06 |
52-Week Price Change | -42.58% |
50-Day Moving Average | 1.45 |
200-Day Moving Average | 1.73 |
Relative Strength Index (RSI) | 72.49 |
Average Volume (20 Days) | 389,849 |
Short Selling Information
The latest short interest is 534,445, so 0.82% of the outstanding shares have been sold short.
Short Interest | 534,445 |
Short Previous Month | 585,928 |
Short % of Shares Out | 0.82% |
Short % of Float | 1.41% |
Short Ratio (days to cover) | 0.59 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -72.37M |
Pretax Income | -58.52M |
Net Income | -65.43M |
EBITDA | -72.34M |
EBIT | -72.37M |
Earnings Per Share (EPS) | -$0.72 |
Full Income Statement Balance Sheet
The company has $154.49 million in cash and n/a in debt, giving a net cash position of $154.49 million or $2.38 per share.
Cash & Cash Equivalents | 154.49M |
Total Debt | n/a |
Net Cash | 154.49M |
Net Cash Per Share | $2.38 |
Equity (Book Value) | 139.11M |
Book Value Per Share | 2.03 |
Working Capital | 138.29M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$43.57 million and capital expenditures -$122,000, giving a free cash flow of -$43.69 million.
Operating Cash Flow | -43.57M |
Capital Expenditures | -122,000 |
Free Cash Flow | -43.69M |
FCF Per Share | -$0.67 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Zura Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -69.23% |
Shareholder Yield | -69.23% |
Earnings Yield | -49.09% |
FCF Yield | -32.78% |
Analyst Forecast
The average price target for Zura Bio is $12.67, which is 518.05% higher than the current price. The consensus rating is "Buy".
Price Target | $12.67 |
Price Target Difference | 518.05% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |